Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04570930 · ClinicalTrials.gov registry record · NA
Improving Outcomes for Care Partners of Persons With Traumatic Brain Injury
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 257
- Enrollment target
NCT04570930: Completed NA study, sponsored by University of Michigan.
NCT04570930 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 257 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04570930, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 257 participants
- Enrollment target
Study Summary
Care partners of persons with traumatic brain injury (TBI) are often faced with considerable physical and emotional stress resulting from their caregiver role. The researchers hypothesize that the care partners who receive the intervention will show improvements in caregiver strain and mental health.
Primary Outcome
TBI-CareQOL Caregiver Strain assesses perceived feelings of feeling overwhelmed, stressed and "beat-down" related to the care partner role. Self-reported responses are on a Likert scale. The measure is scored on a T metric with a mean of 50 and a standard deviation of 10. Higher scores indicate more strain.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Just-in-time adaptive intervention (JITAI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2020-12-09 |
| Est. Completion | 2023-08-19 |
| Phase | NA |
What the finished NCT04570930 record still lists
NCT04570930 is an interventional study that assigns participants to a tested intervention. The registered 257 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT04570930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04570930 about?
NCT04570930 is a clinical study titled "Improving Outcomes for Care Partners of Persons With Traumatic Brain Injury". Care partners of persons with traumatic brain injury (TBI) are often faced with considerable physical and emotional stress resulting from their caregiver role. The researchers hypothesize that the care partners who receive the intervention will show improvements in caregiver strain and mental health...
What is the current status of trial NCT04570930?
This trial is currently completed. It is a NA study. The enrollment target is 257 participants. The study started on 2020-12-09. Estimated completion is 2023-08-19.
What interventions are being tested in trial NCT04570930?
The interventions under investigation include: Control (BEHAVIORAL), Just-in-time adaptive intervention (JITAI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04570930?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04570930's enrollment target sits among peer trials
257 403rd of 2000 higher than 1,597 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03618550 · 257 participants · Phase 2
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- NCT04674267 · 257 participants · NA
Resilience and Equity in Aging, Cancer, and Health (REACH)
- NCT06099288 · 257 participants · NA
Strong Families Start at Home/Familias Fuertes Comienzan en Casa
- NCT06207084 · 257 participants · NA
The Fit With Us Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI